Cerebrolysin ameliorates learning and memory impairments and depression in a ketamine-based animal model of schizophrenia

Cerebrolysin ameliorates learning and memory impairments and depression in a ketamine-based animal model of schizophrenia


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: لیلا حسینی , ویدا مافی کندی , نسرین ابوالحسن پور

عنوان کنگره / همایش: چهاردهمین کنگره علوم اعصاب پایه و بالینی , , تهران , 2025

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله لیلا حسینی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه روانپزشکی و علوم رفتاری
کد مقاله 89475
عنوان فارسی مقاله Cerebrolysin ameliorates learning and memory impairments and depression in a ketamine-based animal model of schizophrenia
عنوان لاتین مقاله Cerebrolysin ameliorates learning and memory impairments and depression in a ketamine-based animal model of schizophrenia
نوع ارائه سخنرانی
عنوان کنگره / همایش چهاردهمین کنگره علوم اعصاب پایه و بالینی
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش
شهر محل برگزاری کنگره/ همایش تهران
سال انتشار/ ارائه شمسی 1404
سال انتشار/ارائه میلادی 2025
تاریخ شمسی شروع و خاتمه کنگره/همایش 1404/09/19 الی 1404/09/21
آدرس لینک مقاله/ همایش در شبکه اینترنت https://bcncongress.ir/
آدرس علمی (Affiliation) نویسنده متقاضی Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
لیلا حسینیاول
ویدا مافی کندیدوم
نسرین ابوالحسن پورسوم

اطلاعات تفضیلی
hide/show

عنوان متن
خلاصه مقالهIntroduction: Cerebrolysin (CBL), a peptide prep from porcine brain tissue, is known for its neuroprotective and anti-inflammatory effects. This study aimed to assess CBL's therapeutic potential in a ketamine-induced mouse model of schizophrenia. Specifically, it examined its effects on anxiety- and depression-like behaviors, spatial memory, modulation of the tryptophan–kynurenine (TRP/KYN) pathway, and inflammatory responses in the prefrontal cortex (PFC). Methods: Thirty-six male BALB/c mice were randomly assigned to three experimental groups: (1) control, (2) ketamine (Ket; 20 mg/kg/day, i.p, and (3) Ket + CBL (2.5 mL/kg/day, i.p). Anxiety-like behavior and locomotor activity were evaluated using the open field test, while depression-like behavior was assessed with the tail suspension test. Spatial memory performance was measured using the Lashley III Maze. Levels of KYN and TRP were quantified with enzyme-linked immunosorbent assay (ELISA). Expression of the inflammatory markers NLRP3 and IL-1β in the PFC was determined via Western blot analysis. Results: The findings showed that CBL administration significantly reduced anxiety-like behaviors, decreased immobility time, and enhanced spatial learning and memory performance. Additionally, CBL treatment notably lowered KYN levels while increasing TRP concentrations in the PFC. Ketamine administration was linked to higher IL-1a expression; however, CBL did not significantly affect NLRP3 and IL-1a levels compared to the Ket group. Conclusion: These results highlight the neuroprotective potential of CBL, suggesting that its beneficial effects may be attributed to modulation of the TRP/KYN pathway, along with improvements in spatial memory, anxiety-like, and depression-like behaviors in the ketamine-induced mouse model of schizophrenia.
کلمات کلیدیMemory ; Cerebrolysin ; Depression ; Anxiety ; Schizophrenia ; Neuroinflammation

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Oral 2025.jpg1404/10/15147977دانلود
Abstract.pdf1404/10/15130380دانلود